An Allogeneic PBMC–Organoid Co-culture Platform for Evaluating Immunotherapy Efficacy and T-Cell-Mediated Antitumor Immunity

Liangshan Hu, Yadong Liu, You Chen, Jiajia Ma, Jing Li, Jie Liu, Donglin Cao

Open source

DOI
10.1021/acsabm.6c01270
Published
2026-11-10
Container
ACS Applied Bio Materials
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsabm.6c01270,
  title = {An Allogeneic PBMC–Organoid Co-culture Platform for Evaluating Immunotherapy Efficacy and T-Cell-Mediated Antitumor Immunity},
  author = {Liangshan Hu and Yadong Liu and You Chen and Jiajia Ma and Jing Li and Jie Liu and Donglin Cao},
  year = {2026},
  journal = {ACS Applied Bio Materials},
  doi = {10.1021/acsabm.6c01270},
  url = {https://doi.org/10.1021/acsabm.6c01270}
}

RIS

TY  - JOUR
TI  - An Allogeneic PBMC–Organoid Co-culture Platform for Evaluating Immunotherapy Efficacy and T-Cell-Mediated Antitumor Immunity
AU  - Liangshan Hu
AU  - Yadong Liu
AU  - You Chen
AU  - Jiajia Ma
AU  - Jing Li
AU  - Jie Liu
AU  - Donglin Cao
PY  - 2026
JO  - ACS Applied Bio Materials
DO  - 10.1021/acsabm.6c01270
UR  - https://doi.org/10.1021/acsabm.6c01270
ER  - 

APA

Hu, L., Liu, Y., Chen, Y., Ma, J., Li, J., Liu, J., & Cao, D. (2026). An Allogeneic PBMC–Organoid Co-culture Platform for Evaluating Immunotherapy Efficacy and T-Cell-Mediated Antitumor Immunity. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c01270

Source records